MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Top Cited Papers
Open Access
- 29 April 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 5 (4), e93
- https://doi.org/10.1371/journal.pmed.0050093
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease associated with substantial morbidity and mortality. The objective of this study was to determine whether there is a peripheral blood protein signature in IPF and whether components of this signature may serve as biomarkers for disease presence and progression. We analyzed the concentrations of 49 proteins in the plasma of 74 patients with IPF and in the plasma of 53 control individuals. We identified a combinatorial signature of five proteins—MMP7, MMP1, MMP8, IGFBP1, and TNFRSF1A—that was sufficient to distinguish patients from controls with a sensitivity of 98.6% (95% confidence interval [CI] 92.7%–100%) and specificity of 98.1% (95% CI 89.9%–100%). Increases in MMP1 and MMP7 were also observed in lung tissue and bronchoalveolar lavage fluid obtained from IPF patients. MMP7 and MMP1 plasma concentrations were not increased in patients with chronic obstructive pulmonary disease or sarcoidosis and distinguished IPF compared to subacute/chronic hypersensitivity pneumonitis, a disease that may mimic IPF, with a sensitivity of 96.3% (95% CI 81.0%–100%) and specificity of 87.2% (95% CI 72.6%–95.7%). We verified our results in an independent validation cohort composed of patients with IPF, familial pulmonary fibrosis, subclinical interstitial lung disease (ILD), as well as with control individuals. MMP7 and MMP1 concentrations were significantly higher in IPF patients compared to controls in this cohort. Furthermore, MMP7 concentrations were elevated in patients with subclinical ILD and negatively correlated with percent predicted forced vital capacity (FVC%) and percent predicted carbon monoxide diffusing capacity (DLCO%). Our experiments provide the first evidence for a peripheral blood protein signature in IPF to our knowledge. The two main components of this signature, MMP7 and MMP1, are overexpressed in the lung microenvironment and distinguish IPF from other chronic lung diseases. Additionally, increased MMP7 concentration may be indicative of asymptomatic ILD and reflect disease progression.Keywords
This publication has 44 references indexed in Scilit:
- Matrilysin (Matrix Metalloproteinase-7) Mediates E-Cadherin Ectodomain Shedding in Injured Lung EpitheliumThe American Journal of Pathology, 2003
- Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung InjuryCell, 2002
- Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosisThorax, 2002
- Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humansProceedings of the National Academy of Sciences of the United States of America, 2002
- Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseasesRespirology, 2002
- Overexpression of Matrix Metalloproteinase-7 in Pulmonary FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.European Respiratory Journal, 2002
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Mortality in Mexican Patients with Chronic Pigeon Breeder's Lung Compared with Those with Usual Interstitial PneumoniaAmerican Review of Respiratory Disease, 1993
- Collagenase in the Lower Respiratory Tract of Patients with Idiopathic Pulmonary FibrosisThe New England Journal of Medicine, 1979